Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 (Severe Coronavirus Disease 2019)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04346056
What this trial is testing

Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19

Who this might be right for
Coronavirus Disease (COVID-19)COVID-19
Ain Shams University 500
Post-approval studies (Phase 4)Study completedNCT04479202
What this trial is testing

The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19

Who this might be right for
BerberineCOVID-19
Chinese Medical Association 76
Post-approval studies (Phase 4)UnknownNCT04639375
What this trial is testing

Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19)

Who this might be right for
SARS-CoV-2
E-MO Biology Inc 300
Large-scale testing (Phase 3)Study completedNCT04509973
What this trial is testing

Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia

Who this might be right for
Covid19Hypoxia
Scandinavian Critical Care Trials Group 1,000
Not applicableStudy completedNCT04397822
What this trial is testing

COVID-19 : Study of INFLAmmasome and PLAtelets Functions

Who this might be right for
COVID-19
University Hospital, Toulouse 61
Testing effectiveness (Phase 2)Study completedNCT04761822
What this trial is testing

COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

Who this might be right for
SARS-CoV InfectionCOVID-19Allergic Reaction+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 746
Not applicableStudy completedNCT04412551
What this trial is testing

Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19

Who this might be right for
Corona Virus InfectionVirus DiseasesCoronaviridae Infections
Dalarna County Council, Sweden 72
Not applicableEnded earlyNCT04569851
What this trial is testing

Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)

Who this might be right for
COVID-19 Infection
Savana Research 100,000
Testing effectiveness (Phase 2)Study completedNCT04532372
What this trial is testing

Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed
City of Hope Medical Center 2
Large-scale testing (Phase 3)Study completedNCT04838795
What this trial is testing

Sisonke (Together): OPEN LABEL TRIAL COVID-19

Who this might be right for
SARS (Severe Acute Respiratory Syndrome)
Wits Health Consortium (Pty) Ltd 477,102
Large-scale testing (Phase 3)Study completedNCT04678739
What this trial is testing

Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial

Who this might be right for
Covid19Covid-19 ARDS
M Abdur Rahim Medical College and Hospital 205
Not applicableUnknownNCT04453540
What this trial is testing

FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context

Who this might be right for
Infectious DiseasePneumoniaMolecular Diagnosis+2 more
Central Hospital, Nancy, France 150
Testing effectiveness (Phase 2)UnknownNCT04977960
What this trial is testing

Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19

Who this might be right for
COVID-19 Acute Respiratory Distress Syndrome
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 180
Early research (Phase 1)Study completedNCT05525910
What this trial is testing

Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants

Who this might be right for
Biological AvailabilityHealthy Participants
Pfizer 15
Early research (Phase 1)Study completedNCT04644120
What this trial is testing

Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
CoronaVirus Disease-2019 (COVID-19)
AbbVie 25
Not applicableStudy completedNCT04937582
What this trial is testing

Cognitive and Psychological Disorders After Severe COVID-19 Infection

Who this might be right for
COVID 19
Central Hospital, Nancy, France 76
Not applicableStudy completedNCT04330261
What this trial is testing

Clinical Characteristics and Outcomes of Pediatric COVID-19

Who this might be right for
COVID-19SARS-CoV-2 InfectionPediatric ALL+2 more
University of Calgary 10,610
Testing effectiveness (Phase 2)Ended earlyNCT04322773
What this trial is testing

Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure

Who this might be right for
Corona Virus Disease
Marius Henriksen 20
Early research (Phase 1)Study completedNCT04449276
What this trial is testing

Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Who this might be right for
Severe Acute Respiratory SyndromeCoronavirusSARS-CoV-2+1 more
CureVac 280
Post-approval studies (Phase 4)Study completedNCT04394117
What this trial is testing

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

Who this might be right for
Coronavirus Disease 2019COVID-19
The George Institute 787
Next Page